Meeting
2021 ASCO Annual Meeting
Automated computed tomography (CT)-derived skeletal muscle mass determination as a significant prognostic factor in colorectal cancer patients using deep neural network model.
Authors
Dongjin Seo
Yonsei University College of Medicine, Seoul, South Korea
Dongjin Seo , Han Sang Kim , Yu Rang Park
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3534)
DOI
10.1200/JCO.2021.39.15_suppl.3534
Abstract #
3534
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Clinical implications of muscle mass and quality in early-stage colorectal cancer (CRC).
First Author: Jessica Hopkins
Poster
2017 Gastrointestinal Cancers Symposium
Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma.
First Author: Go Ninomiya
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic factors for anti-angiogenic treatment in patients with metastatic colorectal cancer: New insights for an old issue from a single institution experience.
First Author: Eleonora Lai
Poster
2023 ASCO Genitourinary Cancers Symposium
Early switching to pembrolizumab (Pe) during first-line platinum-based chemotherapy (PCT) in patients (pts) with metastatic urothelial carcinoma (mUC).
First Author: Yuki Endo